➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Harvard Business School
Boehringer Ingelheim
Colorcon
McKesson

Last Updated: July 14, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089410


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 089410 describes POLOCAINE, which is a drug marketed by Dentsply Pharm and Fresenius Kabi Usa and is included in seven NDAs. It is available from two suppliers. Additional details are available on the POLOCAINE profile page.

The generic ingredient in POLOCAINE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for 089410
Tradename:POLOCAINE
Applicant:Fresenius Kabi Usa
Ingredient:mepivacaine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 089410
Physiological EffectLocal Anesthesia
Medical Subject Heading (MeSH) Categories for 089410
Suppliers and Packaging for NDA: 089410
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
POLOCAINE mepivacaine hydrochloride INJECTABLE;INJECTION 089410 ANDA A-S Medication Solutions 50090-4408 50090-4408-0 1 VIAL, MULTI-DOSE in 1 BAG (50090-4408-0) > 50 mL in 1 VIAL, MULTI-DOSE
POLOCAINE mepivacaine hydrochloride INJECTABLE;INJECTION 089410 ANDA Fresenius Kabi USA, LLC 63323-296 63323-296-57 25 VIAL, MULTI-DOSE in 1 TRAY (63323-296-57) > 50 mL in 1 VIAL, MULTI-DOSE (63323-296-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2%
Approval Date:Dec 1, 1986TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Boehringer Ingelheim
Express Scripts
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.